Bio-Techne Corporation (TECH) Stock Grade

About Bio-Techne Corporation's fundamentals

Bio-Techne Corporation is a $11.4 billion biotechnology company with a net margin of 15.0%, indicating solid profitability on its revenue base, though revenue declined 0.4% year-over-year suggesting recent headwinds in growth. The company trades at a P/E ratio of 60.6, reflecting a significant premium relative to the broader market, while return on equity stands at 8.6%, indicating moderate efficiency in generating profits from shareholder capital. With a dividend yield of just 0.5%, the company prioritizes reinvestment over cash returns to shareholders.